Advertisement
News
Advertisement

Apollo Endosurgery Names Former Covidien Chairman and CEO Richard J. Meelia to Board of Directors

Mon, 05/21/2012 - 3:45am
The Associated Press

(http://www.apolloendo.com)

Apollo Endosurgery, Inc., a company focused on the development of

devices that advance therapeutic endoscopy to enable an entirely new

generation of endoscopic surgical procedures, today announced that

Richard J. Meelia, former CEO and Chairman of Covidien plc, will be

joining the company's Board of Directors.

"Apollo Endosurgery has the potential to lead a fundamental change in

patient care in gastrointestinal surgery, including the important

areas of gastrointestinal cancer and bariatrics," Meelia said. "The

company is at the forefront of endoscopic surgery, a field that

combines the therapeutic benefits of surgery with the minimally

invasive advantages of flexible endoscopy. By aligning itself with the

top international experts in the field of minimally invasive surgery

and medical devices, Apollo Endosurgery will continue to enable

surgeons and gastroenterologists to offer less invasive treatment

options and excellent patient care."

Meelia will fill a newly-created seat on the Apollo Endosurgery board,

joining Dennis L. McWilliams, the founder, President and CEO of Apollo

Endosurgery; Matthew S. Crawford, Founding Managing Director of PTV

Sciences; Bruce Roberson, Ph.D., Managing Director of H.I.G.

BioVentures; Jack Nielsen, Partner, Novo A/S; John Creecy, CEO of

Remeditex; and R. Kent McGaughy, Jr., Managing Director of CPMG, Inc.

Meelia's appointment will be effective July 1, 2012.

Meelia recently retired from his position as Chairman and CEO of

Covidien, a leading global healthcare products company. He led

Covidien's spinoff from Tyco in 2007 where he had served as President

of Tyco Healthcare since 1995. During his tenure at Tyco Healthcare

and Covidien, Meelia directed the company's integration and product

development efforts, growing the business from $600 million in sales

to over $10 billion by 2010. Prior to joining Tyco Healthcare, Meelia

was President of Infusaid, Inc., a division of Pfizer Hospital

Products Group. He also held sales and marketing positions with the

Pharmaseal and McGaw divisions of the American Hospital Supply

Corporation. Meelia holds an MBA from Boston College and an

undergraduate degree from Saint Anselm College.

Mr. Meelia is also a member of the Board of Directors of Triangle,

Inc., a career empowerment network for people with disabilities as

well as Chairman of the Board of Haeomonetics, a company that develops

processes to help hospitals and blood banks efficiently and safely

manage blood supplies. He also serves on the Board of Governors of the

Tufts-New England Medical Center and the Board of Trustees of St.

Anselm College.

"We are pleased to leverage Rich's years of experience as the Chairman

and CEO of one of the world's largest surgical supplies and medical

device makers. Rich has a valuable track record of leadership in

company growth and a deep knowledge of the medical device, hospital

and surgical supply industries," McWilliams said. "Rich's commitment

to Apollo Endosurgery will complement and enhance our position as an

innovator and a driving force in advancing this new class of less

invasive endoscopic surgery devices and procedures. We welcome him to

our board."

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is dedicated to revolutionizing patient care

through the advancement of endoscopic surgery, which is emerging from

the convergence of laparoscopic surgery and therapeutic endoscopy.

Endoscopic surgery minimizes the trauma of surgical access by taking

advantage of natural orifices to deliver surgical tools to targeted

areas. All of Apollo's products are compatible with existing flexible

endoscope platforms. Apollo Endosurgery was cofounded with the Apollo

Group, a unique collaboration of physicians from the Mayo Clinic,

Johns Hopkins University, Medical University of South Carolina, the

University of Texas Medical Branch and the Chinese University of Hong

Kong. This collaboration developed a broad portfolio of patents in the

field of endoscopic surgery that became the foundation of Apollo

Endosurgery. The company has also received a grant from the Cancer

Prevention Research Institute of Texas.

Apollo Endosurgery, OverStitch? and SuMO? are either registered

trademarks or trademarks of Apollo Endosurgery, Inc. in the US and/or

other countries.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading